Cefuroxime Brand Change
As advised via Pharmac Tender announcement 31 May 2017, there is to be a change in the listing and future sole supply.
New listing HML from 1 November 2017 (due to supply issues listed one month earlier than tender announcement)
Cefuroxime Actavis Inj 750 mg 10 vial Pharmacode 2528894 Schedule price $9.85
Cefuroxime Actavis Inj 1.5 g 10 vial Pharmacode 2528908 Schedule price $14.36
Zinacef Inj 750 mg 5 vial Pharmacode 276340 Schedule price $3.70
Zinacef Inj 1.5 g 1 vial Pharmacode 276359 Schedule price $1.30
Delisting HML 1 February 2018. (All stocks are depleted)
Alternative product available
m-Cefuroxime Inj 750 mg 5 vial Pharmacode 2378140
Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.
Click here to read GSK notification.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.